Induction chemotherapy with and without erlotinib in patients with oral cavity squamous cell carcinomas (OCSCCs) amenable for surgical resection.

Authors

Xiuning Le

Xiuning Le

The University of Texas MD Anderson Cancer Center, Houston, TX

Xiuning Le , Curtis R. Pickering , M. Laura Rubin , Frederico Netto , Merrill S. Kies , Faye M. Johnson , Charles Lu , George R. Blumenschein, Jr. Jr., Diana Bell , Lawrence E. Ginsberg , Kaye F Wilson , Jeff Lewis , Lei Feng , Jing Wang , J. Jack Lee , William Nassib William Jr., Jeffrey Myers

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT01927744

Citation

J Clin Oncol 37, 2019 (suppl; abstr 6067)

DOI

10.1200/JCO.2019.37.15_suppl.6067

Abstract #

6067

Poster Bd #

56

Abstract Disclosures

Similar Posters